# RADREMI (NCT04047602)

> Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: brain metastases on immunotherapy

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04047602
- Phase: NA
- Status: TERMINATED
- Sponsor: Indiana University
- Conditions: Brain Tumor; Brain Metastases; Brain Cancer
- Interventions: Reduced Dose SRS
- Enrollment: 18
- Primary outcome: Symptomatic Radiation Necrosis Proportion

## Indexed commentary on RADREMI so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 8 posts on X
- 1 podcast episode

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=radremi-nct04047602

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04047602", "email": "<work email>"}; the inbox owner confirms by the emailed link.